Showing results 1 to 1 of 1
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Neratinib in the extended adjuvant treatment of patients from Asia with early-stage HER2+ breast cancer after trastuzumab-based therapy: exploratory analyses from the phase III ExteNET trial Proceeding/Conference:San Antonio Breast Cancer Congress (SABCS) | 2017 | 60 |